a**********t
发帖数: 631 | 1 new data from Chicago trial 125 patients 113 severe “the best news is most
of our patients have been discharged”
希望hydroxychloroquine的临床测试加快速度。
重症用remdesivir,轻症和预防用hydroxychloroquine，复工就有希望了。
https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus
-drug-suggests-patients-are-responding-to-treatment/ |
c******2
发帖数: 4019 | |
l*****u
发帖数: 94 | 3 其实好消息。125病人大部分是重症，死亡率只有2%左右。 |
r**********r
发帖数: 1 | 4 我知道的一个大公司的人力总监在轻转重后主动要求自愿用药的康复的，那是差不多5
个星期以前的事情，但是美国恶化成现在的这个状况 .....
【在 c******2 的大作中提到】
: 西雅图第一例的论文，已经说的很清楚了。还有奎宁
|
l*****u
发帖数: 94 | 5 HOUSTON也有好消息。
-(April 16, 2020) - COVID-19 patients in a clinical trial at Houston
Methodist Hospital are responding quickly to the antiviral drug Remdesivir.
The trial's criteria allows for the treatment of patients early in their
clinical course and, in some cases, at times where they might have otherwise
been intubated.
"Early results are promising“ |
